Results 201 to 210 of about 44,698 (259)

Editorial: Overcoming resistance to immune checkpoint inhibitors: mechanisms and strategies in cancer therapy. [PDF]

Front Immunol
Piccinelli M, Pizzutilo EG, Gemelli M, Sarhan D, Cavalieri S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adoptive immunotherapy

Current Opinion in Oncology, 1997
Some of the most dramatic advances in the treatment of cancer have used the immune system in combination with conventional or transplantation chemotherapy. Adoptive immunotherapy has been used for relapses after allogeneic bone marrow transplantation, and it has been particularly effective for chronic myeloid leukemia.
K, Ballen, F M, Stewart
openaire   +2 more sources

Adoptive immunotherapy for cancer

Immunological Reviews, 2013
SummaryRecent clinical success has underscored the potential for immunotherapy based on the adoptive cell transfer (ACT) of engineered T lymphocytes to mediate dramatic, potent, and durable clinical responses. This success has led to the broader evaluation of engineered T‐lymphocyte‐based adoptive cell therapy to treat a broad range of malignancies. In
Marco, Ruella, Michael, Kalos
openaire   +2 more sources

Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer

Cancer Treatment Reviews, 2001
The chemo-immunotherapy (CIT) and chemo-adoptive immunotherapy (CAIT) regimens tested in the past decade are summarized. From them we have learned a great deal about the interactions between various chemotherapeutic agents, immune modulating agents and effector cells.
G G, Gomez, R B, Hutchison, C A, Kruse
openaire   +2 more sources

Adoptive Immunotherapy for Malignant Glioma

The Cancer Journal, 2003
Despite remarkable advancements in imaging modalities and treatment options available to patients diagnosed with malignant brain tumors, the prognosis for those with high-grade lesions remains poor. The imprecise mechanisms of currently available treatments to manage these tumors do not spare damage to the normal surrounding brain and often result in ...
Duane A, Mitchell, Peter E, Fecci, John H, Sampson   +2 more
openaire   +2 more sources

Mononuclear Cell Adoptive Immunotherapy

Hematology/Oncology Clinics of North America, 1994
In contrast with red cells, platelets, and granulocytes, hemotherapy using lymphocytes and monocytes is only beginning to be explored. Blood banks and transfusion services, the traditional sources of expertise in sterile cell processing, storage, and transfusion, have played an integral role in the early technical development of mononuclear cell ...
J H, Lee, H G, Klein
openaire   +2 more sources

Enhancing adoptive immunotherapy of cancer

Expert Opinion on Biological Therapy, 2010
Conventional therapies, including surgery, chemotherapy and radiotherapy have contributed much to cancer treatment. However, these treatment modalities fail in a large proportion of patients, and there is a great need for effective alternate therapies.
Jennifer A, Westwood, Linda J, Berry, Leanne Xj, Wang, Connie Pm, Duong, Hollie J, Pegram, Phillip K, Darcy, Michael H, Kershaw   +6 more
openaire   +2 more sources

Adoptive immunotherapy of HCMV infection

Cytotherapy, 2007
Human cytomegalovirus (HCMV) infection or reactivation is a frequent cause of morbidity and mortality in immunocompromised individuals such as transplant recipients. Primary HCMV infection or reactivation of HCMV from latency is mostly asymptomatic in immunocompetent individuals and is controlled by the host's cell-mediated immune response.
M, Kapp, S M, Tan, H, Einsele, Gu, Grigoleit   +3 more
openaire   +2 more sources

Costimulatory approaches to adoptive immunotherapy

Current Opinion in Oncology, 1998
Costimulation is critical for induction of full T-cell effector function, and thus represents an attractive immunotherapeutic approach for the treatment of cancer. This review examines these approaches, including ex vivo T-cell expansion, systemic "delivery" of constimulation, tumors transduced or transfected with costimulatory ligands, and vaccine ...
D N, Liebowitz, K P, Lee, C H, June
openaire   +2 more sources

Adoptive immunotherapy against sarcomas

Expert Opinion on Biological Therapy, 2014
Conventional treatments reached an unsatisfactory therapeutic plateau in the treatment of advanced unresectable bone and soft tissue sarcomas that remain an unsolved medical need. Several evidences support the concept that adoptive immunotherapy may effectively integrate within the complex and multidisciplinary treatment of sarcomas.In this work we ...
Mesiano, Giulia, Leuci, Valeria, Giraudo, Lidia, Gammaitoni, Loretta, Carnevale Schianca, Fabrizio, Cangemi, Michela, Rotolo, Ramona, Capellero, Sonia, Pignochino, Ymera, Grignani, Giovanni, Aglietta, Massimo, Sangiolo, Dario   +11 more
openaire   +2 more sources